| |
| |
|
| Insider
Information: |
Deptula-Hicks Darlene M |
| Relationship: |
See Remarks |
| City: |
Wakefield |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
154,055 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$190,260 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
154,055 |
|
|
| Total
Value |
$190,260 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Accelpath Inc |
ACLP |
Director |
2006-03-15 |
20,000 |
|
0 |
Premium* |
|
|
ICAD Inc |
ICAD |
Exec VP Finance, CFO |
2011-03-03 |
125,055 |
2007-07-18 |
0 |
Premium* |
|
|
Pieris Pharmaceuticals, Inc. |
PIRS |
SVP, Chief Financial O... |
2016-06-13 |
5,000 |
2016-06-13 |
0 |
Premium* |
|
|
T2 Biosystems, Inc. |
TTOO |
SVP & Chief Financial ... |
2017-06-06 |
4,000 |
2017-06-06 |
0 |
Premium* |
|
|
F-star Therapeutics, Inc |
FSTX |
See Remarks |
2023-03-08 |
0 |
2021-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FSTX |
F-star Therapeutics, Inc |
See Remarks |
• – – |
2023-03-08 |
4 |
D |
$7.12 |
$181,838 |
D/D |
(25,539) |
0 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
See Remarks |
• – – |
2023-03-08 |
4 |
D |
$7.12 |
$219,994 |
D/D |
(30,898) |
25,539 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Treasurer and CFO |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
56,437 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Treasurer and CFO |
• – – |
2020-11-20 |
4/A |
A |
$0.00 |
$0 |
D/D |
26,437 |
26,437 |
0 |
- |
|
| TTOO |
T2 Biosystems, Inc. |
SVP & Chief Financial Officer |
• – – |
2017-06-06 |
4 |
B |
$3.58 |
$14,320 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
| PIRS |
Pieris Pharmaceuticals, I... |
SVP, Chief Financial Officer |
• – – |
2016-06-13 |
4 |
B |
$1.66 |
$8,300 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| ICAD |
ICAD Inc |
Exec VP Finance, CFO |
• – – |
2011-03-03 |
4 |
D |
$1.24 |
$6,334 |
D/D |
(5,108) |
125,055 |
0 |
- |
|
| ICAD |
ICAD Inc |
EVP of Finance,CFO |
• – – |
2010-07-19 |
4 |
D |
$2.00 |
$8,816 |
D/D |
(4,408) |
130,163 |
0 |
- |
|
| ICAD |
ICAD Inc |
Exec VP Finance, CFO |
• – – |
2010-06-01 |
4 |
D |
$1.43 |
$9,457 |
D/D |
(6,613) |
134,571 |
0 |
- |
|
| ICAD |
ICAD Inc |
Executive VP of Finance, CFO |
• – – |
2010-03-11 |
4 |
S |
$1.40 |
$27,481 |
D/D |
(19,629) |
141,184 |
0 |
- |
|
| ICAD |
ICAD Inc |
Executive VP of Finance, CFO |
• – – |
2010-03-10 |
4 |
S |
$1.40 |
$7,239 |
D/D |
(5,170) |
160,813 |
0 |
- |
|
| ICAD |
ICAD Inc |
Executive VP of Finance, CFO |
• – – |
2010-03-09 |
4 |
S |
$1.41 |
$283 |
D/D |
(201) |
165,983 |
0 |
- |
|
| ICAD |
ICAD Inc |
Exec VP of Finance, CFO |
• – – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
166,184 |
0 |
- |
|
| ICAD |
ICAD Inc |
Executive VP of Finance, CFO |
• – – |
2009-07-18 |
4 |
D |
$1.18 |
$5,201 |
D/D |
(4,408) |
116,184 |
0 |
- |
|
| ICAD |
ICAD Inc |
Exec VP of Finance, CFO |
• – – |
2008-07-18 |
4 |
D |
$2.84 |
$12,519 |
D/D |
(4,408) |
120,592 |
0 |
- |
|
| ICAD |
ICAD Inc |
EVP of Finance, CFO |
• – – |
2008-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
125,000 |
0 |
- |
|
| ICAD |
ICAD Inc |
Executive VP of Finance, CFO |
• – – |
2007-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| ACLP |
Accelpath Inc |
Director |
– • – |
2006-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
